These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17594180)

  • 21. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
    Johansson BE; Matthews JT; Kilbourne ED
    Vaccine; 1998; 16(9-10):1009-15. PubMed ID: 9682352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system.
    Na HN; Kim KH; Song MK; Park HL; Lee EY; Shim SH; Park S; Nam JH
    Microbiol Immunol; 2013 Sep; 57(9):660-4. PubMed ID: 23822120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing the Yield and Quality of Influenza Virus-like Particles (VLPs) Produced in Insect Cells by Inhibiting Cytopathic Effects of Matrix Protein M2.
    Zak AJ; Hill BD; Rizvi SM; Smith MR; Yang M; Wen F
    ACS Synth Biol; 2019 Oct; 8(10):2303-2314. PubMed ID: 31487465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza.
    Tang XC; Lu HR; Ross TM
    Vaccine; 2010 Oct; 28(42):6821-31. PubMed ID: 20727393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
    Musthaq SK; Kumar SR; Szyporta M; Kwang J
    Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
    Morçӧl T; Hurst BL; Tarbet EB
    Vaccine; 2017 Aug; 35(35 Pt B):4569-4577. PubMed ID: 28716554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches to improved influenza vaccination.
    Betts RF; Treanor JJ
    Vaccine; 2000 Feb; 18(16):1690-5. PubMed ID: 10689150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing perspective on immunization against influenza.
    Johansson BE; Brett IC
    Vaccine; 2007 Apr; 25(16):3062-5. PubMed ID: 17276554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
    Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
    Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coimmunization with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H5N1 vaccine against heterologous virus.
    Zhang Z; Zhang J; Zhang J; Li Q; Miao P; Liu J; Li S; Huang J; Liao M; Fan H
    Vet Microbiol; 2017 May; 203():143-148. PubMed ID: 28619136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults.
    Lakey DL; Treanor JJ; Betts RF; Smith GE; Thompson J; Sannella E; Reed G; Wilkinson BE; Wright PF
    J Infect Dis; 1996 Oct; 174(4):838-41. PubMed ID: 8843225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
    Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insect larvae biofactories as a platform for influenza vaccine production.
    Gomez-Casado E; Gomez-Sebastian S; Núñez MC; Lasa-Covarrubias R; Martínez-Pulgarín S; Escribano JM
    Protein Expr Purif; 2011 Sep; 79(1):35-43. PubMed ID: 21421054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
    Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
    Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X
    Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: a phase I trial in Taiwan.
    Pan SC; Kung HC; Kao TM; Wu H; Dong SX; Hu MH; Chou AH; Chong P; Hsieh SM; Chang SC
    J Microbiol Immunol Infect; 2013 Dec; 46(6):448-55. PubMed ID: 23022464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.